These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 22149317)

  • 41. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.
    Bozzette SA; Ake CF; Tam HK; Chang SW; Louis TA
    N Engl J Med; 2003 Feb; 348(8):702-10. PubMed ID: 12594314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Anaesthesia for HIV-infected patients].
    Bornard L; Blay M; Roger PM; Raucoules-Aimé M; Carles M
    Ann Fr Anesth Reanim; 2011 Jun; 30(6):501-11. PubMed ID: 21684100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The future of antiretroviral therapy: challenges and needs.
    Moreno S; López Aldeguer J; Arribas JR; Domingo P; Iribarren JA; Ribera E; Rivero A; Pulido F;
    J Antimicrob Chemother; 2010 May; 65(5):827-35. PubMed ID: 20228080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.
    Venkat A; Piontkowsky DM; Cooney RR; Srivastava AK; Suares GA; Heidelberger CP
    Ann Emerg Med; 2008 Sep; 52(3):274-85. PubMed ID: 18358567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secondary complications and co-infections in the HIV-infected adolescent in the antiretroviral era.
    Ross AC; Camacho-Gonzalez A; Chahroudi A; Chakraborty R
    Curr Opin Infect Dis; 2011 Jun; 24(3):212-8. PubMed ID: 21455061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular Disease and HIV Infection.
    Klein D; Hurley LB; Sidney S
    N Engl J Med; 2003 Nov; 349(19):1869-70; author reply 1869-70. PubMed ID: 14602888
    [No Abstract]   [Full Text] [Related]  

  • 47. Endothelial and platelet function alterations in HIV-infected patients.
    Gresele P; Falcinelli E; Sebastiano M; Baldelli F
    Thromb Res; 2012 Mar; 129(3):301-8. PubMed ID: 22192157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiretroviral molecules and cardiovascular diseases.
    Gibellini D; Borderi M; Clò A; Morini S; Miserocchi A; Bon I; Re MC
    New Microbiol; 2012 Oct; 35(4):359-75. PubMed ID: 23109004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in HIV-associated cardiovascular diseases in Africa.
    Syed FF; Sani MU
    Heart; 2013 Aug; 99(16):1146-53. PubMed ID: 23680889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Select updates from the 16th CROI: treatment-related cardiovascular risk, pharmacokinetic issues, and interleukin-2 use.
    Boyle BA; Cohen CJ; DeJesus E; Elion R; Frank I; Moyle GJ; Sax PE
    AIDS Read; 2009 Apr; 19(4):158-60. PubMed ID: 19388184
    [No Abstract]   [Full Text] [Related]  

  • 51. Arterial hypertension and cardiovascular risk in HIV-infected patients.
    Calò LA; Caielli P; Maiolino G; Rossi G
    J Cardiovasc Med (Hagerstown); 2013 Aug; 14(8):553-8. PubMed ID: 23807242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid metabolism and cardiovascular risk in HIV infection: new perspectives and the role of nevirapine.
    Podzamczer D
    AIDS Rev; 2013; 15(4):195-203. PubMed ID: 24192600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
    Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
    HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular disease associated with human immunodeficiency virus: a review.
    Costa LA; Almeida AG
    Rev Port Cardiol; 2015; 34(7-8):479-91. PubMed ID: 26162286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV and coronary heart disease: time for a better understanding.
    Boccara F; Lang S; Meuleman C; Ederhy S; Mary-Krause M; Costagliola D; Capeau J; Cohen A
    J Am Coll Cardiol; 2013 Feb; 61(5):511-23. PubMed ID: 23369416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular involvements in HIV-infected patients.
    Alharethi R
    Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1227-35. PubMed ID: 23972010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular disease in human immunodeficiency virus.
    Cheruvu S; Holloway CJ
    Intern Med J; 2014 Apr; 44(4):315-24. PubMed ID: 24754684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complications of Treatment in Youth with HIV.
    Eckard AR; Fowler SL; Haston JC; Dixon TC
    Curr HIV/AIDS Rep; 2016 Aug; 13(4):226-33. PubMed ID: 27234970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cardiovascular and metabolic complications of HIV infection.
    Krishnaswamy G; Chi DS; Kelley JL; Sarubbi F; Smith JK; Peiris A
    Cardiol Rev; 2000; 8(5):260-8. PubMed ID: 11174904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology of cardiovascular involvement in HIV disease and AIDS.
    Fisher SD; Lipshultz SE
    Ann N Y Acad Sci; 2001 Nov; 946():13-22. PubMed ID: 11762981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.